Table 2. Total Number of Visits for Each Section in Tasks 1 and 2*
SectionTask 1Task 2
Contents†806691
Highlights193152
Indications and usage448272
Dosage and administration subsection: Considerations for patient and product selection3521
Dosage and administration318221
Dosage forms and strengths296214
Contraindications269206
Warnings and precautions252199
Adverse reactions254196
Drug interactions247193
Use in specific populations238181
Overdosage236177
Description221179
Clinical pharmacology217183
Nonclinical toxicology211176
Clinical studies207282
How supplied220175
Patient counseling202145
Adverse reactions subsection: clinical trials—18
Clinical pharmacology subsection: mechanism of action—14

  • ↵* Task 1 was a general review of the prescribing information. Task 2 was an efficacy-focused review of the prescribing information.

  • ↵† All participants started on the Contents page; thus 500 of these visits were by default. Participants could visit a section multiple times.